A detailed history of Private Advisor Group, LLC transactions in Geron Corp stock. As of the latest transaction made, Private Advisor Group, LLC holds 168,173 shares of GERN stock, worth $586,923. This represents 0.0% of its overall portfolio holdings.

Number of Shares
168,173
Previous 179,168 6.14%
Holding current value
$586,923
Previous $759,000 0.53%
% of portfolio
0.0%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$4.17 - $4.99 $45,849 - $54,865
-10,995 Reduced 6.14%
168,173 $763,000
Q2 2024

Aug 05, 2024

SELL
$3.1 - $5.09 $7,387 - $12,129
-2,383 Reduced 1.31%
179,168 $759,000
Q1 2024

Apr 30, 2024

SELL
$1.75 - $3.44 $296,787 - $583,399
-169,593 Reduced 48.3%
181,551 $599,000
Q4 2023

Feb 06, 2024

BUY
$1.74 - $2.31 $6,190 - $8,218
3,558 Added 1.02%
351,144 $740,000
Q3 2023

Nov 02, 2023

BUY
$2.11 - $3.28 $91,966 - $142,962
43,586 Added 14.34%
347,586 $736,000
Q2 2023

Aug 09, 2023

BUY
$1.97 - $3.69 $205,077 - $384,129
104,100 Added 52.08%
304,000 $975,000
Q1 2023

May 10, 2023

BUY
$2.14 - $3.4 $310,835 - $493,850
145,250 Added 265.78%
199,900 $433,000
Q4 2022

Jan 18, 2023

BUY
$2.03 - $2.42 $40,599 - $48,400
20,000 Added 57.72%
54,650 $0
Q3 2022

Oct 14, 2022

BUY
$1.67 - $2.94 $4,175 - $7,350
2,500 Added 7.78%
34,650 $82,000
Q2 2022

Jul 13, 2022

BUY
$1.19 - $1.65 $22,859 - $31,696
19,210 Added 148.45%
32,150 $50,000
Q1 2022

May 12, 2022

BUY
$0.99 - $1.6 $12,810 - $20,704
12,940 New
12,940 $18,000
Q2 2021

Aug 12, 2021

SELL
$1.25 - $1.83 $19,125 - $27,999
-15,300 Closed
0 $0
Q1 2021

Apr 22, 2021

BUY
$1.52 - $2.1 $3,116 - $4,305
2,050 Added 15.47%
15,300 $24,000
Q4 2020

Apr 01, 2021

SELL
$1.55 - $2.05 $5,580 - $7,379
-3,600 Reduced 21.36%
13,250 $21,000
Q2 2020

Aug 17, 2020

BUY
$1.05 - $2.18 $464 - $963
442 Added 2.69%
16,850 $37,000
Q1 2020

May 12, 2020

BUY
$0.89 - $1.49 $14,603 - $24,447
16,408 New
16,408 $20,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.32B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.